179 related articles for article (PubMed ID: 37005236)
1. [Development of an Inhalation Dry Powder Preparation Method without Heat-drying Process].
Ito T
Yakugaku Zasshi; 2023; 143(4):353-358. PubMed ID: 37005236
[TBL] [Abstract][Full Text] [Related]
2. Naked pDNA/hyaluronic acid powder shows excellent long-term storage stability and gene expression in murine lungs.
Ito T; Fukuhara M; Okuda T; Okamoto H
Int J Pharm; 2020 Jan; 574():118880. PubMed ID: 31811928
[TBL] [Abstract][Full Text] [Related]
3. Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.
Farinha S; Sá JV; Lino PR; Galésio M; Pires J; Rodrigues MÂ; Henriques J
Pharm Res; 2023 May; 40(5):1115-1140. PubMed ID: 36456666
[TBL] [Abstract][Full Text] [Related]
4. Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology.
Tanaka R; Hattori Y; Otsuka M; Ashizawa K
Drug Dev Ind Pharm; 2020 Feb; 46(2):179-187. PubMed ID: 31937148
[TBL] [Abstract][Full Text] [Related]
5. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.
Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC
Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924
[TBL] [Abstract][Full Text] [Related]
6. Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation.
Hou A; Li L; Huang Y; Singh V; Zhu C; Pan X; Quan G; Wu C
Drug Deliv Transl Res; 2018 Jun; 8(3):693-701. PubMed ID: 29600480
[TBL] [Abstract][Full Text] [Related]
7. Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides.
Eedara BB; Alabsi W; Encinas-Basurto D; Polt R; Mansour HM
AAPS PharmSciTech; 2021 Jun; 22(5):185. PubMed ID: 34143327
[TBL] [Abstract][Full Text] [Related]
8. Bovine serum albumin as a lyoprotectant for preparation of DNA dry powder formulations using the spray-freeze drying method.
Tsukamoto M; Okuda T; Okamoto H; Higuchi Y; Kawakami S; Yamashita F; Hashida M
Biol Pharm Bull; 2012; 35(7):1178-81. PubMed ID: 22791169
[TBL] [Abstract][Full Text] [Related]
9. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.
Acosta MF; Muralidhran P; Abrahamson MD; Grijalva CL; Carver M; Tang H; Klinger C; Fineman JR; Black SM; Mansour HM
Pulm Pharmacol Ther; 2020 Dec; 65():101998. PubMed ID: 33556627
[TBL] [Abstract][Full Text] [Related]
10. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
[TBL] [Abstract][Full Text] [Related]
11. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
Acosta MF; Abrahamson MD; Encinas-Basurto D; Fineman JR; Black SM; Mansour HM
AAPS J; 2020 Nov; 23(1):2. PubMed ID: 33200330
[TBL] [Abstract][Full Text] [Related]
12. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
13. [Development of Inhalable Dry Powder Formulations Loaded with Nanoparticles Maintaining Their Original Physical Properties and Functions].
Okuda T
Yakugaku Zasshi; 2017; 137(11):1339-1348. PubMed ID: 29093369
[TBL] [Abstract][Full Text] [Related]
14. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
Saboti D; Maver U; Chan HK; Planinšek O
J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
[TBL] [Abstract][Full Text] [Related]
15. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
[TBL] [Abstract][Full Text] [Related]
16. Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity.
Okuda T; Morishita M; Mizutani K; Shibayama A; Okazaki M; Okamoto H
J Control Release; 2018 Jun; 279():99-113. PubMed ID: 29627404
[TBL] [Abstract][Full Text] [Related]
17. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
Azari F; Ghanbarzadeh S; Safdari R; Yaqoubi S; Adibkia K; Hamishehkar H
Drug Res (Stuttg); 2020 Jan; 70(1):26-32. PubMed ID: 31533157
[TBL] [Abstract][Full Text] [Related]
18. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
[TBL] [Abstract][Full Text] [Related]
19. Formulation techniques for high dose dry powders.
Brunaugh AD; Smyth HDC
Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.
Wu X; Zhang W; Hayes D; Mansour HM
Int J Nanomedicine; 2013; 8():1269-83. PubMed ID: 23569375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
